Skip to content

Clinical trials

Lymphoma, T-Cell, Peripheral trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Country / region: China Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20112
20141
20152
20162
20176
20184
20196
202015
20214
202211
202315
202414
202511
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status45
Recruiting34
Completed10
Not yet recruiting6
Active, not recruiting5
Terminated5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine9
Ruijin Hospital8
Sun Yat-sen University8
Fudan University6
Dizal Pharmaceuticals4
Institute of Hematology & Blood Diseases Hospital, China4
Peking Union Medical College Hospital4
Henan Cancer Hospital3
Peking University3
Second Affiliated Hospital, Zhejiang University, School of Medicine3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral106
Recurrence17
Lymphoma, Non-Hodgkin7
Lymphoma, T-Cell7
Immunoblastic Lymphadenopathy6
Lymphoma, Large-Cell, Anaplastic5
Lymphoma, Extranodal NK-T-Cell4
Lymphoma, Large B-Cell, Diffuse4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma4
Lymphoma3

Trials

Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.